GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lincoln Pharmaceuticals LINCOLN.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

520.85

+2.62%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹6.23bn

FY2016FY2025

Net income

₹823.5m

FY2016FY2025

Free cash flow

₹737.7m

FY2016FY2025

Shareholders' equity

₹6.72bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₹6.23bn₹5.81bn₹5.10bn₹4.72bn₹4.24bn₹3.86bn₹3.66bn₹3.62bn₹3.65bn₹4.00bn
Gross profit₹3.19bn₹2.89bn₹2.57bn₹2.44bn₹2.18bn₹2.04bn₹1.82bn₹1.68bn₹1.43bn₹1.23bn
Operating income₹886.3m₹893.1m₹805.5m₹877.0m₹798.0m₹582.1m₹608.0m₹462.0m₹412.6m₹361.5m
Net income₹823.5m₹933.0m₹729.0m₹693.6m₹622.2m₹514.4m₹487.1m₹346.2m₹281.2m₹236.8m
Diluted earnings per share41.1146.5936.4034.6331.0625.6824.3817.3014.0611.84

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₹7.97bn₹7.00bn₹5.87bn₹5.34bn₹4.59bn₹3.89bn₹3.66bn₹3.47bn₹3.05bn₹2.76bn
Cash and short-term investments₹1.96bn₹1.52bn₹1.14bn₹1.15bn₹921.9m₹489.3m₹258.3m₹255.8m₹220.1m₹135.6m
Total liabilities₹1.25bn₹1.07bn₹849.5m₹1.01bn₹840.8m₹763.0m₹966.4m₹1.23bn₹1.13bn₹1.32bn
Debt—₹10.7m₹20.0m₹20.4m₹1.4m₹46.8m₹317.9m₹554.7m₹574.3m₹718.4m
Shareholders' equity₹6.72bn₹5.93bn₹5.02bn₹4.33bn₹3.75bn₹3.13bn₹2.69bn₹2.24bn₹1.92bn₹1.44bn
Shares outstanding20m20m20m20m20m20m20m20m20m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₹930.2m₹632.2m₹392.6m₹761.3m₹692.7m₹754.2m₹528.4m₹266.3m₹250.4m₹448.0m
Capital spending−₹192.4m−₹396.1m−₹142.8m−₹455.3m−₹87.5m−₹76.9m−₹149.4m−₹99.0m−₹176.2m−₹337.3m
Free cash flow₹737.7m₹236.0m₹249.8m₹306.1m₹605.2m₹677.2m₹379.1m₹167.3m₹74.3m₹110.7m
Dividends paid−₹36.1m−₹30.0m−₹30.0m−₹30.0m—−₹72.3m−₹36.2m−₹28.7m−₹19.6m−₹19.7m

Latest quarters

By quarter end

Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024
Revenue₹1.66bn₹1.63bn₹1.54bn₹1.68bn₹1.47bn₹1.61bn₹1.47bn₹1.42bn
Gross profit₹903.6m₹866.2m₹846.8m₹880.3m₹779.2m₹889.2m₹770.4m₹689.2m
Operating income₹198.8m₹218.1m₹203.3m₹234.9m₹204.4m₹251.5m₹195.1m₹157.0m
Net income₹286.0m₹199.8m₹276.8m₹115.8m₹207.7m₹263.3m₹236.7m₹186.0m
Diluted earnings per share14.289.9813.825.7810.3713.1511.829.28
Cash from operations—₹497.0m—₹506.0m—₹423.0m—₹223.0m
Capital spending—−₹108.0m—−₹113.0m—−₹79.0m—−₹314.0m
Free cash flow—₹389.0m—₹393.0m—₹344.0m—−₹91.0m
Total assets—₹8.55bn—₹7.97bn—₹7.80bn—₹7.00bn
Cash and short-term investments—₹2.35bn—₹1.97bn—₹2.00bn—₹1.53bn
Debt—₹668,000———₹13.6m—₹10.7m
Shareholders' equity—₹7.16bn—₹6.72bn—₹6.39bn—₹5.93bn

Financial ratios

Data as of 3 Oct 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin32.8%53.3%51.2%51.3%52.6%51.4%——
Operating margin12.4%14.2%14.3%15.4%35.5%20.6%——
Net margin13.1%13.2%16.1%14.4%14.8%15.0%——
Return on equity11.6%12.3%15.7%14.5%16.0%17.0%——
Return on assets9.9%10.3%13.3%12.4%13.0%13.8%——
Free cash flow yield11.4%9.6%8.8%4.6%10.4%6.7%——
Revenue growth7.7%7.4%15.0%7.9%12.9%10.1%——
Earnings growth6.7%-11.7%28.0%5.1%11.4%21.0%——
Current ratio5.25x4.71x4.84x5.09x3.90x4.07x——
Debt to equity0.01x0.00x0.00x0.00x0.00x0.00x——
Equity ratio85.1%84.3%84.7%85.5%81.0%81.0%——
Interest coverage82.12x47.05x56.81x38.42x114.69x54.61x——
R&D as a share of sales—1.7%1.9%2.3%—2.3%2.2%2.5%
Buybacks as a share of market value-0.0%-0.0%0.0%0.0%0.0%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.7%10.0%8.9%
Operating income0.4%8.8%15.1%
Net income5.9%9.9%18.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.5%50.7%51.1%46.9%
Operating margin14.8%15.8%16.2%14.5%
Net margin14.6%14.5%14.4%12.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings11.816.916.810.311.69.48.312.916.815.6
Price to sales1.62.72.41.51.71.31.11.21.30.9

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 12 Sept 2025.

FY2026FY2025FY2024FY2023FY2022FY2020FY2019FY2018
Paid in the year1.801.801.501.501.503.001.501.20

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.